// App-Quantinova.ai

S4294 2016 AHA : Incidence of Major Adverse Cardiovascular Events After Chronic Total Occlusion Percutaneous Coronary Intervention: Insights From a Multicenter Registry

Researchers

Presenter

  • Aris Karatasakis

Principal Investigators

  • Anthony Doing

  • Craig Thompson

  • Subhash Banerjee

  • Emmanouil Brilakis

  • Philip Dattilo

  • Phuong-Khanh J Nguyen-Trong

  • Judit Karacsonyi

  • Aya Alame

  • Erica Resendes

  • Pratik Kalsaria

  • Bavana Rangan

  • Michele Roesle

Medical Centers

  • VA North Texas Healthcare System and UT Southwestern Medical Center, Dallas, TX

  • Medical Ctr of the Rockies, Loveland, CO

Locations

  • United States

Companies

  • Boston Scientific

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Chronic total occlusion

  • Acute Coronary Syndromes

  • Myocardial infarction

  • Diabetes

  • Venous thrombosis

  • Stroke

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim